Periodic Reporting for period 2 - TCRabX (Structural basis for the therapeutic efficiency of optimal-affinity T cell receptors)

A malignant solid tumour is a life-threatening disease that is difficult to cure. Currently, solid tumours are treated with classical therapies such as surgery, chemotherapy and radiation. Adoptive T cell therapy represents an alternative treatment method that can attack the...